Vol 71, No 3 (2020)
Clinical vignette
Published online: 2020-04-15
Unusual case of radioactive iodine-induced Graves’ disease with orbitopathy following total thyroidectomy in a patient with papillary thyroid microcarcinoma
1
, 23, 23
, 23, 23
Abstract
Not required for Clinical Vignette.
Keywords: Graves’ diseaseGraves’ orbitopathyradioiodinethyroidectomyTSH-receptor antibodies
References
- Schmidt M, Gorbauch E, Dietlein M, et al. Incidence of postradioiodine immunogenic hyperthyroidism/Graves' disease in relation to a temporary increase in thyrotropin receptor antibodies after radioiodine therapy for autonomous thyroid disease. Thyroid. 2006; 16(3): 281–288.
- Vannucchi G, Campi I, Covelli D, et al. Graves' orbitopathy activation after radioactive iodine therapy with and without steroid prophylaxis. J Clin Endocrinol Metab. 2009; 94(9): 3381–3386.
- Shen G, Cui F, Huang R, et al. Graves disease following radioiodine therapy for toxic adenoma: Clinical case report. Medicine (Baltimore). 2017; 96(45): e8550.
- Yürekli Y, Cengiz A, Güney E. Graves Disease Induced by Radioiodine Therapy for Toxic Nodular Goiter: A Case Report. Mol Imaging Radionucl Ther. 2015; 24(3): 135–137.
- Aoyama M, Takizawa H, Tsuboi M, et al. A case of metastatic follicular thyroid carcinoma complicated with Graves’ disease after total thyroidectomy. Endocr J. 2017; 64(12): 1143–1147.
